What is it about?

The paper connects supply chain risk management (SCRM) to medicine supply chains by operationalizing the risk management strategies in the medical context . We develop insights on the role policymakers play and how they directly implement and indirectly influence the adoption of strategies. Based on our findings, we develop a framework that captures the diverse roles of policymakers in SCRM..

Featured Image

Read the Original

This page is a summary of: Supply chain risk management strategies in normal and abnormal times: policymakers' role in reducing generic medicine shortages, International Journal of Physical Distribution & Logistics Management, September 2022, Emerald,
DOI: 10.1108/ijpdlm-12-2021-0511.
You can read the full text:

Read

Contributors

The following have contributed to this page